
Core Viewpoint - Adient's recent earnings report showed a significant decline in both earnings and revenue, leading to a downward revision of guidance for fiscal 2024, indicating potential challenges ahead for the company [2][6]. Financial Performance - Adient reported adjusted earnings per share (EPS) of 32 cents for Q3 fiscal 2024, down from 98 cents in the same period last year, and missed the Zacks Consensus Estimate of 67 cents [2]. - The company generated net sales of 3.81 billion [2]. Segmental Performance - The Americas segment recorded revenues of 1.76 billion, but adjusted EBITDA increased to 95 million [3]. - The EMEA segment's revenues were 1.35 billion, with adjusted EBITDA dropping significantly to 103 million [4]. - The Asia segment reported revenues of 729 million, while adjusted EBITDA rose 1% to 890 million, down from 2.4 billion, with capital expenditures totaling 60 million in the prior-year quarter [5]. Revised Guidance - Adient revised its fiscal 2024 revenue guidance to 14.80-870 million, down from 920 million [6]. Market Position - Adient has a Zacks Rank 5 (Strong Sell), indicating expectations of below-average returns in the coming months [9]. - The company has an average Growth Score of C and a Momentum Score of D, but a strong value score of A, placing it in the top quintile for this investment strategy [8].